Hypera S.A Cash Flow Conversion Efficiency
Hypera S.A cash flow conversion efficiency. Based on the latest financial reports, Hypera S.A (HYPE3) has a cash flow conversion efficiency ratio of 0.028x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$403.70 Million ≈ $79.21 Million USD) by net assets (R$14.43 Billion ≈ $2.83 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Hypera S.A (2006–2025)
Cash flow conversion efficiency of Hypera S.A from 2006 to 2025. This chart illustrates how Hypera S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Hypera S.A stock price today for real-time trading data and today's change.
Hypera S.A Cash Flow Conversion Ratio Explained
Hypera S.A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Hypera S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hypera S.A ranked by their cash flow conversion efficiency. Also see HYPE3 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China South Publishing & Media Group Co Ltd
SHG:601098
|
-0.022x |
|
Bavarian Nordic
CO:BAVA
|
0.042x |
|
ERMENEGILDO ZEG.DL -0001
F:JN0
|
N/A |
|
First BanCorp
F:OLWN
|
0.072x |
|
L&K Engineering Suzhou Co Ltd
SHG:603929
|
0.248x |
|
TIZA Information Industry Corporation Inc
SHE:300209
|
-0.015x |
|
Brookfield Business Partners L.P.
TO:BBU-UN
|
0.049x |
|
COFCO Capital Holdings Co Ltd
SHE:002423
|
0.249x |
Annual Cash Flow Conversion Efficiency for Hypera S.A (2006–2025)
The table below shows the annual cash flow conversion efficiency of Hypera S.A from 2006 to 2025. Review Hypera S.A free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | R$12.52 Billion ≈ $2.46 Billion |
R$1.43 Billion ≈ $280.27 Million |
0.114x | -45.65% |
| 2024-12-31 | R$12.10 Billion ≈ $2.37 Billion |
R$2.54 Billion ≈ $498.32 Million |
0.210x | +0.88% |
| 2023-12-31 | R$11.52 Billion ≈ $2.26 Billion |
R$2.40 Billion ≈ $470.14 Million |
0.208x | +8.72% |
| 2022-12-31 | R$10.66 Billion ≈ $2.09 Billion |
R$2.04 Billion ≈ $400.05 Million |
0.191x | +34.48% |
| 2021-12-31 | R$9.83 Billion ≈ $1.93 Billion |
R$1.40 Billion ≈ $274.53 Million |
0.142x | +11.14% |
| 2020-12-31 | R$9.24 Billion ≈ $1.81 Billion |
R$1.18 Billion ≈ $232.14 Million |
0.128x | +35.35% |
| 2019-12-31 | R$8.71 Billion ≈ $1.71 Billion |
R$823.88 Million ≈ $161.66 Million |
0.095x | -26.67% |
| 2018-12-31 | R$8.27 Billion ≈ $1.62 Billion |
R$1.07 Billion ≈ $209.27 Million |
0.129x | +7.03% |
| 2017-12-31 | R$7.74 Billion ≈ $1.52 Billion |
R$932.61 Million ≈ $183.00 Million |
0.121x | +19.04% |
| 2016-12-31 | R$8.71 Billion ≈ $1.71 Billion |
R$881.76 Million ≈ $173.02 Million |
0.101x | +151.20% |
| 2015-12-31 | R$8.03 Billion ≈ $1.58 Billion |
R$323.69 Million ≈ $63.51 Million |
0.040x | -54.62% |
| 2014-12-31 | R$7.48 Billion ≈ $1.47 Billion |
R$664.00 Million ≈ $130.29 Million |
0.089x | -5.57% |
| 2013-12-31 | R$7.08 Billion ≈ $1.39 Billion |
R$665.78 Million ≈ $130.64 Million |
0.094x | -9.50% |
| 2012-12-31 | R$6.87 Billion ≈ $1.35 Billion |
R$713.80 Million ≈ $140.06 Million |
0.104x | +19.04% |
| 2011-12-31 | R$6.65 Billion ≈ $1.30 Billion |
R$580.23 Million ≈ $113.85 Million |
0.087x | +556.93% |
| 2010-12-31 | R$5.06 Billion ≈ $992.69 Million |
R$67.24 Million ≈ $13.19 Million |
0.013x | -76.53% |
| 2009-12-31 | R$3.42 Billion ≈ $670.62 Million |
R$193.50 Million ≈ $37.97 Million |
0.057x | +25.23% |
| 2008-12-31 | R$1.92 Billion ≈ $376.06 Million |
R$86.64 Million ≈ $17.00 Million |
0.045x | -78.25% |
| 2007-12-31 | R$692.69 Million ≈ $135.92 Million |
R$143.97 Million ≈ $28.25 Million |
0.208x | +148.26% |
| 2006-12-31 | R$37.40 Million ≈ $7.34 Million |
R$-16.11 Million ≈ $-3.16 Million |
-0.431x | -- |
About Hypera S.A
Hypera S.A. operates as a pharmaceutical company in Brazil. The company provides sweeteners products under the Adocyl, finn, and Zero-cal brands; analgesics and anti-inflammatories products under the Doril, Atroveran, Calminex, Alivium, Buscopan, Buscofem, geloll, Torsilax, Neosaldina, and naprohax brands; cold and flu remedies and decongestants products under BENEGRIO, Rinosoro, Blu, Neosoro, Co… Read more